IL325935A - Salts and solid forms of compounds that modulate ikzf2 - Google Patents
Salts and solid forms of compounds that modulate ikzf2Info
- Publication number
- IL325935A IL325935A IL325935A IL32593526A IL325935A IL 325935 A IL325935 A IL 325935A IL 325935 A IL325935 A IL 325935A IL 32593526 A IL32593526 A IL 32593526A IL 325935 A IL325935 A IL 325935A
- Authority
- IL
- Israel
- Prior art keywords
- salts
- compounds
- solid forms
- ikzf2
- modulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
- C07C59/50—Mandelic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363516062P | 2023-07-27 | 2023-07-27 | |
| PCT/US2024/039924 WO2025024823A1 (en) | 2023-07-27 | 2024-07-26 | Salts and solid forms of compounds that modulate ikzf2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325935A true IL325935A (en) | 2026-03-01 |
Family
ID=94375569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325935A IL325935A (en) | 2023-07-27 | 2024-07-26 | Salts and solid forms of compounds that modulate ikzf2 |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN121866057A (en) |
| AU (1) | AU2024298553A1 (en) |
| IL (1) | IL325935A (en) |
| TW (1) | TW202515553A (en) |
| WO (1) | WO2025024823A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015003114A (en) * | 2012-09-10 | 2015-07-06 | Celgene Corp | METHODS FOR TREATMENT OF LOCALLY ADVANCED BREAST CANCER. |
| DK3820573T3 (en) * | 2018-07-10 | 2023-10-23 | Novartis Ag | 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES |
| KR20240035820A (en) * | 2021-07-09 | 2024-03-18 | 플렉시움 인코포레이티드 | Aryl compounds and pharmaceutical compositions that modulate IKZF2 |
-
2024
- 2024-07-26 CN CN202480059684.4A patent/CN121866057A/en active Pending
- 2024-07-26 AU AU2024298553A patent/AU2024298553A1/en active Pending
- 2024-07-26 IL IL325935A patent/IL325935A/en unknown
- 2024-07-26 WO PCT/US2024/039924 patent/WO2025024823A1/en active Pending
- 2024-07-29 TW TW113128168A patent/TW202515553A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202515553A (en) | 2025-04-16 |
| WO2025024823A1 (en) | 2025-01-30 |
| AU2024298553A1 (en) | 2026-02-05 |
| CN121866057A (en) | 2026-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL316058A (en) | Kras g12d modulating compounds | |
| PT4185580T (en) | Solid state forms of belumosudil and belumosudil salts | |
| ES3063064T3 (en) | Improved synthesis of kras g12c inhibitor compound | |
| IL288062A (en) | Solid state forms of tafamidis and salts thereof | |
| SG11202109438TA (en) | A salt and crystal form of a fak inhibitor | |
| IL317847A (en) | Salts of sos1 inhibitors | |
| PT4146348T (en) | Inhibitors of nek7 kinase | |
| IL281143A (en) | Salts and crystal forms of gabaa positive allosteric modulator | |
| IL310234A (en) | Salts and solid state forms of a kif18a inhibitor compound | |
| IL321102A (en) | Solid dispersion of a her2 inhibitor | |
| IL304402A (en) | Advantageous morphic form of at-527 hemi-sulfate salt | |
| EP4452967A4 (en) | Inhibitors of sars-cov-2 | |
| IL318393A (en) | Aza-quinazoline compounds and methods of use | |
| SI4192814T1 (en) | Inhibitors of transglutaminases | |
| IL325935A (en) | Salts and solid forms of compounds that modulate ikzf2 | |
| CA3299203A1 (en) | Salts and solid forms of compounds that modulate ikzf2 | |
| IL305791A (en) | Salt and solid forms of a kinase inhibitor | |
| SI4192813T1 (en) | Inhibitors of transglutaminases | |
| PL4441028T3 (en) | Salt of s-oxprenolol | |
| SI4192812T1 (en) | Inhibitors of transglutaminases | |
| IL321700A (en) | Salts and solid forms of sonrotoclax intermediate | |
| GB202316444D0 (en) | Salts of opicapone | |
| IL321828A (en) | Spirocycloalkyl compounds and pharmaceutical compositions that modulate ikzf2 | |
| CA3279207A1 (en) | Solid state forms of brilaroxazine and brilaroxazine salts | |
| HK40128909A (en) | Salts and solid forms of sonrotoclax intermediate |